Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
Status:
Recruiting
Trial end date:
2024-12-24
Target enrollment:
Participant gender:
Summary
Ulcerative colitis (UC) is a chronic relapsing inflammatory bowel disease. UC pathogenesis
remains poorly understood but involves an inappropriate immune response toward an unbalanced
gut microbiota (called dysbiosis) in predisposed hosts.
The purpose of this study is to determine the effect of the fecal microbiota transplantation
on UC.
Phase:
Phase 3
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborators:
CRB-HUEP Institut National de la Santé Et de la Recherche Médicale, France